CONTROLLED TRIAL OF PERGOLIDE MESYLATE IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY

被引：31

作者：

JANKOVIC, J

机构：

来源：

关键词：

D O I：

10.1212/WNL.33.4.505

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：505 / 507

页数：3

共 15 条

[1] DOPAMINE-RECEPTORS EXPLAINED
CREESE, I
[J]. TRENDS IN NEUROSCIENCES, 1982, 5 (02) : 40 - 43
[2] DUVOISIN RC, 1981, NEUROLOGY NY, V31, pA133
[3] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS
GOLDSTEIN, M
LIEBERMAN, A
LEW, JY
ASANO, T
ROSENFELD, MR
MAKMAN, MH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3725 - 3728
[4] GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P253
[5] PARKINSONISM - ONSET PROGRESSION AND MORTALITY
HOEHN, MM
YAHR, MD
[J]. NEUROLOGY, 1967, 17 (05) : 427 - &
[6] JACKSON JA, ANN NEUROL
[7] QUANTITATIVE ASSESSMENT OF PARKINSONIAN AND ESSENTIAL TREMOR - CLINICAL-APPLICATION OF TRIAXIAL ACCELEROMETRY
JANKOVIC, J
FROST, JD
[J]. NEUROLOGY, 1981, 31 (10) : 1235 - 1240
[8] JANKOVIC J, 1981, ANN NEUROL, V10, P64
[9] JANKOVIC J, 1982, CLIN NEUROPHARMACOL, V5, P519
[10] KLAWANS HL, 1979, ANN NEUROL, V6, pA157